Tag: SENATE
-
Pharmaceutical Funding Influence on U.S. Congress Members
– Over two-thirds of Congress received funding from pharmaceutical companies in 2020. – 2023-2024 cycle: $26.4 million to Democrats, $16.1 million to Republicans. – 72 senators received at least $10,000; 12 senators exceeded $100,000. – Pharmaceutical firms are top lobbying spenders, investing $372 million in 2022. Congress and Pharmaceutical ContributionsA significant analysis by Open Secrets…